In a validation study of the DNA microarray dataset using a 70-gene prognosis classifier (Mammaprint®), O'Brien et al. reported that immunohistochemical expression of CENP-F was an important predictor among the genes highly expressed in breast tumors of patients with poor overall survival[22]. The gene discussed is CENPF; the disease is breast neoplasm.